The risk of fractures among patients with cirrhosis or chronic pancreatitis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 2, 2014, Pages 320-326

  Bang, Ulrich Christian ^a   Benfield, Thomas ^a,b   Bendtsen, Flemming ^a,b   Hyldstrup, Lars ^a,b   Beck Jensen, Jens Erik ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Database analysis; Fibrosis; Liver disease; Orthopedic

Indexed keywords

FAT; PANCREAS ENZYME;

ADULT; ALCOHOL ABUSE; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; FRACTURE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MALNUTRITION; MIDDLE AGED; TREATMENT DURATION;

BMD; BONE MINERAL DENSITY; CHRONIC PANCREATITIS; CHRONIC PULMONARY DISEASE; CI; CONFIDENCE INTERVAL; CP; CPD; DATABASE ANALYSIS; FIBROSIS; HAZARD RATIO; HR; INCIDENCE RATE; IR; LIVER DISEASE; ORTHOPEDIC; PANCREATIC ENZYMES SUBSTITUTION; PBC; PERSON-YEARS; PES; PRIMARY BILIARY CIRRHOSIS; PY; RANK; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-ΚB;

ADULT; AGE FACTORS; ALCOHOL DRINKING; COMORBIDITY; DIETARY FATS; FEMALE; FEMORAL FRACTURES; FOREARM INJURIES; FRACTURES, BONE; HUMANS; LEG INJURIES; LIVER CIRRHOSIS; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84892479704     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.04.031     Document Type: Article

References (33)

1. Gansauge F., Gansauge S., Eh M., et al. Distributional and functional alterations of immunocompetent peripheral blood lymphocytes in patients with chronic pancreatitis. Ann Surg 2001, 233:365-370.
2. Saito H., Ishii H. Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res 2004, 30:193-198.
3. Pezzilli R. Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation. World J Gastroenterol 2009, 15:1673-1676.
4. McClain C.J., Barve S.S., Barve A., et al. Alcoholic liver disease and malnutrition. Alcohol Clin Exp Res 2011, 35:815-820.
5. Lynge E., Sandegaard J.L., Rebolj M. The Danish National Patient Register. Scand J Public Health 2011, 39:30-33.
6. Pedersen C.B., Gotzsche H., Moller J.O., et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
7. Chu S.P., Kelsey J.L., Keegan T.H., et al. Risk factors for proximal humerus fracture. Am J Epidemiol 2004, 160:360-367.
8. Tignor A.S., Wu B.U., Whitlock T.L., et al. High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol 2010, 105:2680-2686.
9. Kildemoes H.W., Sorensen H.T., Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011, 39:38-41.
10. Diamond T., Stiel D., Lunzer M., et al. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990, 31:82-87.
11. Boulton-Jones J.R., Fenn R.M., West J., et al. Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment Pharmacol Ther 2004, 20:551-557.
12. Solaymani-Dodaran M., Card T.R., Aithal G.P., et al. Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 2006, 131:1752-1757.
13. Gallego-Rojo F.J., Gonzalez-Calvin J.L., Munoz-Torres M., et al. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998, 28:695-699.
14. Schiefke I., Fach A., Wiedmann M., et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005, 11:1843-1847.
15. Mounach A., Ouzzif Z., Wariaghli G., et al. Primary biliary cirrhosis and osteoporosis: a case-control study. JBone Miner Metab 2008, 26:379-384.
16. Angulo P., Therneau T.M., Jorgensen A., et al. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. JHepatol 1998, 29:729-735.
17. Hay J.E., Lindor K.D., Wiesner R.H., et al. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991, 14:257-261.
18. Gonzalez-Calvin J.L., Mundi J.L., Casado-Caballero F.J., et al. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. JClin Endocrinol Metab 2009, 94:4844-4850.
19. Ormarsdottir S., Ljunggren O., Mallmin H., et al. Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver function. JIntern Med 2002, 252:537-541.
20. Newton J., Francis R., Prince M., et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001, 49:282-287.
21. Campbell M.S., Lichtenstein G.R., Rhim A.D., et al. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis. Liver Int 2005, 25:311-316.
22. Haaber A.B., Rosenfalck A.M., Hansen B., et al. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol 2000, 27:21-27.
23. Mann S.T., Stracke H., Lange U., et al. Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis. Metabolism 2003, 52:579-585.
24. Joshi A., Reddy S.V., Bhatia V., et al. High prevalence of low bone mineral density in patients with tropical calcific pancreatitis. Pancreas 2011, 40:762-767.
25. Hanck C., Rossol S., Hartmann A., et al. Cytokine gene expression in peripheral blood mononuclear cells reflects a systemic immune response in alcoholic chronic pancreatitis. Int J Pancreatol 1999, 26:137-145.
26. Tarrats N., Moles A., Morales A., et al. Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology 2011, 54:319-327.
27. Ferrari-Lacraz S., Ferrari S. Do RANKL inhibitors (denosumab) affect inflammation and immunity?. Osteoporos Int 2011, 22:435-446.
28. De L.C., Kanis J.A., Oden A., et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005, 16:1330-1338.
29. Gonzalez-Reimers E., Alvisa-Negrin J., Santolaria-Fernandez F., et al. Vitamin D and nutritional status are related to bone fractures in alcoholics. Alcohol Alcohol 2011, 46:148-155.
30. Corpechot C., Gaouar F., Chretien Y., et al. Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. JHepatol 2012, 56:218-224.
31. Jackson K.M., Sher K.J., Cooper M.L., et al. Adolescent alcohol and tobacco use: onset, persistence and trajectories of use across two samples. Addiction 2002, 97:517-531.
32. Gonzalez-Calvin J.L., Garcia-Sanchez A., Bellot V., et al. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 1993, 28:571-579.
33. Kanis J.A., Johnell O., Oden A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005, 16:155-162.